98 related articles for article (PubMed ID: 9381872)
1. [Thermostable Yersinia pseudotuberculosis toxin: its isolation, purification and the characteristics of its properties].
Nedashkovskaia EP; Timchenko NF; Besednov AL; Vertiev IuV
Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):5-9. PubMed ID: 9381872
[TBL] [Abstract][Full Text] [Related]
2. [The development of species-specific diagnostic preparations based on a thermostable toxin of Yersinia pseudotuberculosis].
Besednov AL; Nedashkovskaia EP; Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):52-4. PubMed ID: 9432848
[No Abstract] [Full Text] [Related]
3. [Biological properties of heat-labile lethal toxin of Yersinia pseudotuberculosis].
Pokrovskiĭ VK; Timchenko NF; Nedashkovskaia EP; Grigor'eva EA
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):63-6. PubMed ID: 19186548
[TBL] [Abstract][Full Text] [Related]
4. [The action of Yersinia pseudotuberculosis heat stable lethal toxin on the biosynthesis of protein in vitro].
Timchenko NF; Terent'ev LL; Nedashkovskaia EP; Terent'eva NA; Raznik NV; Pridnia OV; Rasskazov VA
Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):15-8. PubMed ID: 15346943
[TBL] [Abstract][Full Text] [Related]
5. Purification and some properties of a lethal toxic fragment of staphylococcal alpha-toxin by tryptic digestion.
Watanabe M; Kato I
Biochim Biophys Acta; 1978 Aug; 535(2):388-400. PubMed ID: 678558
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of alpha-toxin produced by Clostridium novyi type A.
Ball DW; Van Tassell RL; Roberts MD; Hahn PE; Lyerly DM; Wilkins TD
Infect Immun; 1993 Jul; 61(7):2912-8. PubMed ID: 8514395
[TBL] [Abstract][Full Text] [Related]
7. [Yersinia pseudotuberculosis toxins].
Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):83-9. PubMed ID: 17163146
[TBL] [Abstract][Full Text] [Related]
8. [The pathogenetic importance of Yersinia pseudotuberculosis lipopolysaccharide].
Kuznetsova TA; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):37-41. PubMed ID: 9432844
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum.
Ballard J; Bryant A; Stevens D; Tweten RK
Infect Immun; 1992 Mar; 60(3):784-90. PubMed ID: 1541552
[TBL] [Abstract][Full Text] [Related]
10. [The protective properties of a porin from the outer membrane of Yersinia pseudotuberculosis].
Timchenko NF; Novikova OD; Pavlova TN; Venediktov VS; Solov'eva TF
Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):48-50. PubMed ID: 1965874
[TBL] [Abstract][Full Text] [Related]
11. Effect of thermolabile toxin from Yersinia pseudotuberculosis on functions of innate immunity cells.
Plekhova NG; Drobot EI; Timchenko NF; Somova LM; Persiyanova EN
Bull Exp Biol Med; 2014 Aug; 157(4):483-7. PubMed ID: 25110089
[TBL] [Abstract][Full Text] [Related]
12. Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor.
Lockman HA; Gillespie RA; Baker BD; Shakhnovich E
Infect Immun; 2002 May; 70(5):2708-14. PubMed ID: 11953417
[TBL] [Abstract][Full Text] [Related]
13. [Purification and characterization of hec toxin produced by Aeromonas hydrophila].
Tu X; Lin C
Wei Sheng Wu Xue Bao; 1992 Dec; 32(6):432-8. PubMed ID: 1299032
[TBL] [Abstract][Full Text] [Related]
14. A rapid and safe procedure for preparing the murine toxins of the plague bacillus (Yersinia pestis).
Seguin MC; Harrison DN; Williams JE
Toxicon; 1987; 25(9):989-94. PubMed ID: 3433308
[TBL] [Abstract][Full Text] [Related]
15. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
16. [Influence of thermolabile lethal toxin of Yersinia pseudotuberculosis on development of sea urchin embryos and biosynthesis of DNA and RNA in embryonic cells].
Timchenko NF; Terent'eva NA; Pokrovskiĭ VK; Terent'ev LL; Nedashkovskaia EP; Rasskazov VA
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):66-9. PubMed ID: 19186549
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
Yoshino K; Abe J; Murata H; Takao T; Kohsaka T; Shimonishi Y; Takeda T
FEBS Lett; 1994 Dec; 356(1):141-4. PubMed ID: 7988709
[TBL] [Abstract][Full Text] [Related]
18. [Isolation and characteristics of staphylococcal alpha-toxin].
Noskov AN; Ezepchuk IuV
Mol Gen Mikrobiol Virusol; 1985 Mar; (3):34-7. PubMed ID: 3842745
[TBL] [Abstract][Full Text] [Related]
19. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
[TBL] [Abstract][Full Text] [Related]
20. [Use of immunomodulators isolated from marine invertebrates for reducing the toxic effects of thermostable toxin and lipopolysaccharides from Yersinia pseudotuberculosis on a macroorganism].
Kuznetsova TA; Logvinenko AA; Timchenko NF; Epshteĭn LM; Besednova NN
Antibiot Khimioter; 2001; 46(7):11-3. PubMed ID: 11697237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
